hVIVO plc (LON:HVO) Declares GBX 0.20 Dividend

hVIVO plc (LON:HVO) announced a dividend on Tuesday, April 9th, Upcoming.Co.Uk reports. Investors of record on Thursday, April 18th will be given a dividend of GBX 0.20 ($0.00) per share on Monday, May 20th. This represents a yield of 0.68%. The ex-dividend date of this dividend is Thursday, April 18th. The official announcement can be accessed at this link.

hVIVO Stock Up 1.5 %

HVO opened at GBX 27.62 ($0.34) on Wednesday. hVIVO has a 1-year low of GBX 14 ($0.17) and a 1-year high of GBX 32 ($0.40). The stock’s fifty day simple moving average is GBX 28.04 and its 200 day simple moving average is GBX 24.20. The company has a current ratio of 1.46, a quick ratio of 1.16 and a debt-to-equity ratio of 9.83. The stock has a market cap of £187.89 million, a PE ratio of -1.00 and a beta of 0.99.

hVIVO Company Profile

hVIVO plc operates as a pharmaceutical service and contract research company. The company is involved in testing vaccines and antivirals using human challenge clinical trials. It provides services to big pharma, biotech, government, and public health organizations. The company has a portfolio of human challenge study models for conditions, such as RSV, flu, human rhinovirus, asthma, malaria, cough, and COPD, as well as developing COVID-19 human challenge study model.